0003-2814Level 3
ORENCIA (abatacept)
**Product type:** Human Prescription Drug
**Active ingredient:** ABATACEPT
**Strength:** 50 mg/.4mL
**Dosage form:** Injection, Solution
**Route:** Subcutaneous
**Labeler:** E.R. Squibb & Sons, L.L.C.
**Marketing category:** BLA (BLA125118)
**Pharmacologic class:** Decreased Cytokine Activity [PE], Recombinant Fusion Proteins [CS], Selective T Cell Costimulation Modulator [EPC]
GET
/api/v1/systems/ndc_fda/nodes/0003-2814Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.